BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11523539)

  • 1. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
    Griffin BE
    Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus: 40 years on.
    Young LS; Rickinson AB
    Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.
    Bakkalci D; Jia Y; Winter JR; Lewis JE; Taylor GS; Stagg HR
    J Glob Health; 2020 Jun; 10(1):010405. PubMed ID: 32257153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic role of Epstein-Barr virus in human cancer.
    Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
    Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and cancers of the head and neck.
    Goldenberg D; Golz A; Netzer A; Rosenblatt E; Rachmiel A; Goldenberg RF; Joachims HZ
    Am J Otolaryngol; 2001; 22(3):197-205. PubMed ID: 11351290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus: the first human tumor virus and its role in cancer.
    Pagano JS
    Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the global burden of Epstein-Barr virus-related cancers.
    Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
    Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
    J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
    Chang CM; Yu KJ; Mbulaiteye SM; Hildesheim A; Bhatia K
    Virus Res; 2009 Aug; 143(2):209-21. PubMed ID: 19596032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: epidemiologic correlations.
    Anwar N; Kingma DW; Bloch AR; Mourad M; Raffeld M; Franklin J; Magrath I; el Bolkainy N; Jaffe ES
    Cancer; 1995 Oct; 76(7):1245-52. PubMed ID: 8630905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
    Rowe M; Kelly GL; Bell AI; Rickinson AB
    Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Epstein-Barr virus-associated cancers in children.
    Straathof KC; Bollard CM; Rooney CM; Heslop HE
    Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus: a group 1 carcinogen?
    Niedobitek G
    Virchows Arch; 1999 Aug; 435(2):79-86. PubMed ID: 10599304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.
    Simbiri KO; Smith NA; Otieno R; Wohlford EE; Daud II; Odada SP; Middleton F; Rochford R
    PLoS One; 2015; 10(5):e0125420. PubMed ID: 25933165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.